C07D 211/64
Having an aryl radical as the second substituent in position 4
Official title: having an aryl radical as the second substituent in position 4
C07D211/64 (Having an aryl radical as the second substituent in position 4) appears on 127 US grants and 88 published applications in this corpus.
Search patents in C07D- Granted patents
- 127
- Published applications
- 88
- Assignees
- 79
- Inventors
- 361
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 5 | 0 |
| 1978 | 7 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 6 | 1 |
| 2002 | 5 | 3 |
| 2003 | 1 | 3 |
| 2004 | 2 | 10 |
| 2005 | 3 | 7 |
| 2006 | 3 | 14 |
| 2007 | 4 | 9 |
| 2008 | 3 | 6 |
| 2009 | 7 | 8 |
| 2010 | 8 | 5 |
| 2011 | 6 | 3 |
| 2012 | 1 | 3 |
| 2013 | 0 | 0 |
| 2014 | 3 | 4 |
| 2015 | 2 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 2 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and methods for treating cancer29 Apr 2025US 12,286,413 B2Mayo Foundation for Medical Education and Research
- Compounds and methods for treating cancer10 May 2022US 11,325,892 B2Mayo Foundation for Medical Education and Research
- Chemoselective methylene hydroxylation in aromatic molecules30 Mar 2021US 10,961,266 B2The Board of Trustees of the University of Illinois
- 4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors2 Jul 2019US 10,336,729 B2Boehringer Ingelheim International GmbH
- Compounds and methods for treating cancer28 May 2019US 10,301,273 B2Mayo Foundation for Medical Education and Research
- Substituted phenol derivative and use thereof30 Jul 2026US 2026/0217651 A1Chengdu MFS Pharma. Co., Ltd.
- Compounds and methods for treating cancer18 Sep 2025US 2025/0289794 A1Mayo Foundation for Medical Education and Research
- Sweetener compositions11 Sep 2025US 2025/0280861 A1Firmenich SA
- Method for producing amide compound22 May 2025US 2025/0162992 A1Chugai Seiyaku Kabushiki Kaisha
- Phenyl urea derivative19 Sep 2024US 2024/0308960 A1Sumitomo Pharma Co., Ltd.
Most cited
By later US patents
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- Dipeptides which promote release of growth hormone79US 5,936,089 APfizer Inc. · 1999
- Arylalkylamines, process for preparing them and pharmaceutical compositions containing them70US 5,236,921 ASanofi · 1993
- Phenoxyphenylpiperidines52US 4,198,417 AAmerican Hoechst Corporation · 1980
- 2,6-substituted pyridine compounds52US 4,692,184 AMonsanto Company · 1987